Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam besylate + esketamine vs propofol + esketamine for painless enteroscopy
ChiCTR2200066994Phase 4Not yet recruiting
- Sponsor
- Ordos Central Hospital
- Start
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in Anxiety Disorder Due To Another Medical Condition and None comparing Propofol + esketamine with Remimazolam besylate + esketamine (2 arms). Primary endpoint: Operation completion success rate. Planned start Dec 2022; status: not yet recruiting.
02
Drugs
remimazolamesketaminepropofol
03
Conditions
Anxiety Disorder Due To Another Medical Condition
Beyond the preview
Go deeper on ChiCTR2200066994.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200066994.